Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Phase 2/3 Clinical Trial Execution

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract pertains to the execution of Phase 2/3 clinical trials focused on acute pain management, requiring full management of trial operations including site selection, patient recruitment, data collection, and safety monitoring in strict compliance with FDA regulations. The work will be performed in Frederick, Maryland, with a post date of June 29, 2026, and a response deadline of July 30, 2026, at 5:00 PM. This is a subcontract under the Defense Health Agency, part of the Department of Defense, and falls under NAICS code 541711 for research and development in the physical, engineering, and life sciences. All activities must adhere to regulatory standards to ensure trial integrity, patient safety, and data reliability, with performance centered in Frederick, MD.

General Info

Phase 2/3 acute pain trial in Frederick, MD, under DHA, compliant with FDA, response due July 30, 2026.

Agency

Department Of Defense → Defense Health AgencyView Agency

NAICS

541711 - Research and Development in BiotechnologyView NAICS

Place of Performance

Frederick, MD, 21702, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Defense Health Agency
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Manage and execute Phase 2/3 clinical trials for acute pain management, including site selection, patient recruitment, data collection, and safety monitoring under FDA regulations.

Similar Contracts

Same NAICS industry code

NAICS: 541711
Grant
Preclinical Animal Studies for Neurofibromatosis ResearchThe contract seeks to conduct preclinical in vivo studies using genetically engineered mouse models or alternative animal models of neurofibromatosis to assess the efficacy of therapeutic interventions, track tumor progression, and investigate underlying biological mechanisms. The work requires advanced expertise in animal modeling, tumor biology, and preclinical drug evaluation, with a focus on generating robust, reproducible data to support future clinical translation. All studies must be conducted in accordance with established ethical and scientific standards for animal research, with detailed documentation of methodologies, outcomes, and adverse events. This subcontract is issued under the Defense Health Agency Contracting Activity and falls under NAICS code 541711, indicating it supports research and development in the physical, engineering, and life sciences. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is open to qualified entities capable of executing complex preclinical studies. While the place of performance and point of contact details are unspecified, successful proposers must demonstrate capacity to manage animal facilities, comply with regulatory requirements, and deliver high-quality, timely results in support of neurofibromatosis research objectives under the Department of Defense.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541711
Grant
Collaborative Biomedical Research ExecutionThis contract enables a collaborative biomedical research effort focused on neurofibromatosis, requiring coordinated hypothesis-driven investigations led by an Initiating Principal Investigator and a Partnering Principal Investigator. The work encompasses the design of experiments, generation of empirical data, and rigorous milestone-based progress reporting to ensure scientific rigor and accountability. The project is structured as a subcontract under the Defense Health Agency Contracting Activity, falling under the NAICS code for research and development in the physical, engineering, and life sciences, and is intended to advance understanding of neurofibromatosis through integrated scientific contributions. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is managed by the Department of Defense through its health research infrastructure. While no set-aside provisions or specific location details are provided, the emphasis is firmly on outcome-driven research with clearly defined deliverables tied to research milestones. The effort requires close alignment between the two principal investigators to ensure cohesive experimental planning, data integrity, and timely reporting, reflecting a strategic investment in translational medical science with potential implications for defense-relevant health conditions.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541711
Grant
Data Management and Evaluation SupportThe contract titled Data Management and Evaluation Support is a subcontract under the Administration for Community Living, part of the Department of Health and Human Services, aimed at providing comprehensive support for the collection, management, analysis, and evaluation of research and program outcomes. The work must strictly adhere to federal standards to ensure data integrity, compliance, and quality reporting, with a focus on delivering actionable insights that inform program effectiveness and decision-making. The North American Industry Classification System code 541711 identifies this as scientific research and development services, underscoring the technical and analytical nature of the required efforts. Proposals must be submitted by the deadline of July 29, 2026, with the opportunity posted on June 22, 2026. The place of performance and specific office address are not specified, indicating flexibility in where the work may be conducted, though it must align with federal operational requirements. No set-aside type is designated, meaning the subcontract is open to all eligible subcontractors without preference for small businesses or other categories. Interested parties should review the official solicitation link for detailed submission guidelines and technical requirements, as success will depend on demonstrating robust methodologies in data handling, analytical rigor, and compliance with federal regulations governing research and program evaluation.
Administration For Community Living

POSTED

about 1 month ago

DEADLINE

in 3 days
View Details
NAICS: 541711
Grant
Collaborative Research Partnership (Partnering PI Option)This contract establishes a collaborative research partnership where a Partnering Principal Investigator from an external institution will co-lead the research effort alongside the primary team, sharing equal responsibility for scientific direction, project management, and deliverables. Funding is jointly allocated between the participating institutions, ensuring aligned resources and mutual accountability for outcomes, with the work focused on health-related research under the Defense Health Agency Contracting Activity. The initiative falls under NAICS code 541711, indicating it is within the scientific research and development sector, and is structured as a subcontract to support integrated, multi-institutional innovation. The opportunity was posted on June 18, 2026, with a deadline for responses set for September 28, 2026, providing potential partners a defined window to submit proposals. The partnership is expected to be conducted in alignment with the mission of the Department of Defense, addressing critical health priorities through joint scientific leadership. There is no set-aside designation specified, meaning eligibility is open to qualified institutions regardless of size or status, and no specific location is designated for performance, allowing flexibility in where the research activities are carried out as long as the objectives are met collaboratively.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in 2 months
View Details
NAICS: 541711
Grant
Kidney Cancer Clinical Research ExecutionThe contract titled Kidney Cancer Clinical Research Execution aims to advance clinical and translational research focused on kidney cancer through comprehensive scientific activities including study design, patient data collection, biomarker analysis, and therapeutic development. The work is intended to support the development of innovative treatments and diagnostic strategies by integrating clinical observations with laboratory research, ensuring findings are rapidly translated into improved patient outcomes. The project requires expertise in oncology research methodologies, rigorous data management, and interdisciplinary collaboration to address critical gaps in kidney cancer understanding and care. This subcontract is issued by the Defense Health Agency Contracting Activity under the Department of Defense and falls under NAICS code 541711, indicating it is related to research and development in the life sciences. The opportunity was posted on June 18, 2026, with a response deadline of September 28, 2026, providing potential applicants approximately three months to prepare and submit proposals. The place of performance and specific office address details are not specified, suggesting flexibility in location but requiring proposers to align with the overarching objectives of the Department of Defense’s medical research priorities. All work must demonstrate scientific excellence, feasibility, and direct relevance to advancing kidney cancer therapeutics within a clinical context.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in 2 months
View Details
NAICS: 541711
Federal
Infectious Disease Vaccine DevelopmentThe contract involves licensing the NanoFET platform to enable rapid-response vaccine development against viral and bacterial pathogens, leveraging its unique adjuvant-free immune activation and modular antigen integration capabilities. This technology allows for swift adaptation to emerging infectious threats by streamlining the design and production of vaccines without relying on traditional immune-stimulating additives, significantly reducing development timelines and enhancing safety profiles. The work is structured as a subcontract under the Department of Energy, with performance centered at Los Alamos, New Mexico, and is targeted toward advancing national defense and public health preparedness through next-generation vaccine platforms. The opportunity is open for proposals until December 18, 2026, and falls under NAICS code 541711, indicating it targets research and development in the physical, engineering, and life sciences. The contracting entity is Triad, the DOE Contractor, and the initiative aligns with broader federal efforts to build resilient, scalable biodefense capabilities. Participants must demonstrate technical proficiency in the NanoFET platform, experience in infectious disease vaccine design, and the capacity to execute rapid development cycles under strict timelines. Success in this effort will contribute directly to scalable, next-generation immunization technologies capable of addressing current and future biological threats.
Triad - DOE Contractor

POSTED

about 1 month ago

DEADLINE

in 5 months
View Details
NAICS: 541711
Federal
Modular Cancer Immunotherapy DevelopmentThe contract entails the license and development of the NanoFET platform for the creation of targeted cancer immunotherapies, leveraging its modular scaffold to deliver tumor-specific antigens and immune stimulators in a precise and effective manner. The work is focused on advancing next-generation immunotherapeutic approaches by engineering the platform to enhance immune recognition and response against cancer cells, with the goal of improving therapeutic outcomes and reducing off-target effects. The project requires collaboration to optimize the platform’s design, validate its efficacy in preclinical models, and prepare for subsequent clinical translation, all grounded in cutting-edge nanotechnology and immunological science. The contract is a subcontract under the Department of Energy, with performance centered in Los Alamos, New Mexico, 87545, and is classified under NAICS code 541711 for research and development in the physical, engineering, and life sciences. The solicitation was posted on June 17, 2026, with a response deadline of December 18, 2026, indicating a strategic timeline for proposal submission and evaluation. While details on set-aside status and point of contact are not provided, the project is positioned to align with national priorities in advanced biomedical innovation and cancer treatment, leveraging federal research infrastructure and expertise to drive transformative therapeutic solutions.
Triad - DOE Contractor

POSTED

about 1 month ago

DEADLINE

in 5 months
View Details

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 334516
New
Federal
Supply and Delivery of Brand-Name Sleep ChambersThe contract requires the supply and delivery of 12 commercial off-the-shelf brand-name sleep chambers to the Walter Reed Army Institute of Research under F.o.b. Destination terms, with acceptance contingent upon successful inspection upon delivery. The equipment must meet specified standards as brand-name products, ensuring compatibility with research protocols and operational requirements. Delivery is due to a confirmed location in Silver Spring, Maryland, with a zip code of 20910, and performance is governed by the Defense Health Agency under the Department of Defense. The NAICS code 334516 applies, indicating classification within the manufacturing of surgical and medical instrumentation, which aligns with the nature of the sleep chambers as specialized medical devices. The solicitation was posted on July 24, 2026, with a firm response deadline of August 7, 2026, at 2:00 PM. This is structured as a subcontract under the broader DoD procurement framework, with no set-aside designation specified. Delivery must comply with F.o.b. Destination terms, meaning ownership and risk transfer to the government only after the items arrive at the designated site and pass inspection. Failure to meet specifications or deliver on schedule may result in non-acceptance and potential contract termination. All items must be brand-name products, excluding generic or private-label alternatives, and must be fully functional for use in clinical and research environments at the facility in Silver Spring.
Analytical Laboratory Instrument Manufacturing

POSTED

2 days ago

DEADLINE

in 12 days
View Details
NAICS: 621399
New
Federal
Clinical Content Customization & Local Guideline ImplementationThe contract focuses on customizing the Sanford Guide platform with facility-specific antimicrobial guidelines, resistance patterns, and formulary data tailored to the needs of Department of Defense medical centers under the Defense Health Agency. This initiative requires close collaboration with clinical experts across DHA facilities to ensure that the localized content reflects current best practices, institutional policies, and regional antimicrobial resistance trends. The goal is to enhance clinical decision-making by integrating accurate, up-to-date, and contextually relevant infectious disease management tools directly into the Sanford Guide platform used by healthcare providers. Work under this subcontract must be completed in alignment with DHA standards and performed remotely or at the designated place of performance in Falls Church, Virginia, with a response deadline of August 7, 2026. The North American Industry Classification System code 621399 indicates this work falls under other outpatient care centers, emphasizing its clinical and operational nature. The contract does not specify set-aside parameters and is open to eligible subcontractors capable of delivering secure, evidence-based content customization that supports antimicrobial stewardship and improves patient outcomes across military healthcare settings.
Offices of All Other Miscellaneous Health Practitioners

POSTED

2 days ago

DEADLINE

in 12 days
View Details